Transcend Innovation: The cumulative deviation of the stock price increase for two consecutive days exceeds 20%, indicating potential risks.

Tongda Chuangzhi announced that the company's stock had deviated by more than 20% from the closing prices on January 30 and February 2, 2026, for two consecutive trading days, indicating abnormal fluctuations. The company's self-inspection showed that there was no need to correct or supplement the previously disclosed information, no undisclosed significant information affecting the stock price was found, recent operations were normal, and the controlling shareholder and actual controller did not have any undisclosed significant matters to disclose. They did not buy or sell the company's stock during the abnormal fluctuations. There is no need for the company to disclose performance forecasts, and the 2025 annual report will be released on March 27.